Go to the list of all blogs
Serhii Bondarenko's Avatar
published in Blogs
Sep 25, 2026
Why Is Breakwave Tanker Shipping ETF (BWET) Down 9.40% Today?

Why Is Breakwave Tanker Shipping ETF (BWET) Down 9.40% Today?

Key Takeaways

  • BWET fell 9.40% on the day, giving back $64.29 to trade near $620.00 versus a prior close of $684.29.
  • The decline follows a parabolic, multi-thousand-percent year-to-date rally driven by the U.S.–Iran conflict and disruption of the Strait of Hormuz.
  • The move reflects heavy profit-taking and extreme intraday volatility rather than a single fundamental break.
  • Tanker freight futures, the fund's underlying exposure, have swung violently as geopolitical headlines shift daily.
  • Investors are watching for any de-escalation signal that could unwind historically elevated crude tanker freight rates.

Opening Summary

The BWET ETF — the Breakwave Tanker Shipping ETF — provides long exposure to the cost of transporting crude oil by sea through a portfolio of near-dated tanker freight futures, primarily contracts tied to Baltic Exchange tanker freight indexes. In today's session, the fund moved sharply lower, falling 9.40% to roughly $620.00 from a prior closing price of $684.29. The direction was firmly downward, and the session was marked by an exceptionally wide range: the fund opened higher, spiked to an intraday high around $812.14, and then reversed hard as sellers took control. Markets attributed the reversal to profit-taking in one of the most volatile and hotly traded corners of the ETF market after an extraordinary run-up.

What Drove the ETF Move Today

Profit-Taking After a Parabolic Run

The most immediate driver behind today's decline was profit-taking. BWET has been one of the best-performing non-leveraged funds of 2026, surging thousands of percent as U.S.–Iran hostilities shut down large portions of global crude tanker traffic. When a fund's share price rises at that pace, gains become increasingly reflexive: momentum-driven buyers chase the rally, and any pause triggers rapid selling as early holders lock in enormous paper profits. Today's sharp reversal from an intraday high of roughly $812 to near $620 is consistent with that dynamic, as speculative positions were unwound into strength.

Tanker Freight Futures Volatility

BWET tracks freight futures, not physical crude or shipping company equities, so its daily moves are amplified by the leverage inherent in futures and by the extreme sensitivity of freight rates to geopolitical headlines. Since the conflict began in late February, benchmark Middle East-to-China supertanker rates have spiked toward record territory near $1 million per day, and Brent crude has traded back above $100 a barrel. In this environment, small shifts in the perceived odds of escalation versus de-escalation produce outsized swings in the fund. Today's down move came as the market digested the froth in freight pricing, with no fresh escalation catalyst to sustain the latest leg higher.

Which Holdings Contributed Most

BWET does not hold individual equities. Its performance is driven by a rolling portfolio of near-dated tanker freight futures, with a heavy concentration — roughly 90% — in the Baltic Exchange TD3C route, which measures the cost of shipping crude on very large crude carriers (VLCCs) from the Middle East Gulf to China. Because the fund is dominated by a single benchmark route tied to the Strait of Hormuz chokepoint, its returns are overwhelmingly dictated by that one freight curve. Today's decline therefore tracks a pullback in those futures rather than the movement of any single stock, reflecting a cooling of the most extreme freight rate prints of recent weeks.

Market Context and Trading Activity

Trading activity in BWET has been exceptionally elevated and volatile throughout the conflict-driven rally, and today's session was no exception, with a multi-hundred-dollar intraday range. The fund's decline did not align with a broad equity-market selloff; rather, it reflected idiosyncratic pressure within the specialized shipping-futures segment. Peer shipping products with different structures have behaved differently: funds tied to dry bulk freight such as BDRY, and equity-based shipping funds such as BOAT and SEA, have posted far smaller year-to-date gains because they lack the same direct leverage to tanker freight futures. The divergence underscores that today's move was freight-specific and momentum-driven rather than a signal about the broader market.

What Comes Next for BWET

The outlook for BWET hinges almost entirely on the trajectory of the U.S.–Iran conflict and the status of the Strait of Hormuz, through which roughly a fifth of global oil trade passes. Continued disruption keeps vessel-days scarce and freight rates elevated, while any credible de-escalation would likely return tonnage to normal routing and unwind freight rates rapidly. Investors should monitor Baltic Exchange tanker rate indexes, insurance and escort costs, statements from coalition and regional governments on reopening the strait, and fund flows, which can push the share price above or below the value of its underlying futures. Given the fund's leverage to a single chokepoint and its history of extreme daily swings, volatility in both directions is likely to remain a defining feature.

Trending AI Robots

Tickeron's Trending AI Robots page highlights AI-driven trading bots that are performing strongly under current market conditions. Tickeron offers hundreds of AI trading bots covering thousands of tickers, but only the strongest performers are curated into this section, with bots differing by strategy, timeframe, performance metrics, and traded symbols. Explore the Trending AI Robots to see which automated strategies are currently leading the market.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: BWET

Contributor

Serhii Bondarenko is an AI-focused trading strategist and financial markets analyst specializing in the development and application of AI trading bots and autonomous trading agents. His work combines technical analysis, fundamental analysis, and quantitative research to identify market patterns, forecast price movements, and analyze liquidity, volatility, and correlations across global stock markets. Serhii actively publishes market insights, forecasts, and trading frameworks on platforms such as Investing.com and Finextra, with a strong focus on AI-driven decision-making and next-generation algorithmic trading. His research aims to bridge the gap between traditional trading methodologies and advanced artificial intelligence, helping traders and investors navigate complex and rapidly evolving market conditions.


Aroon Indicator for BWET shows an upward move is likely

BWET's Aroon Indicator triggered a bullish signal on September 24, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 141 similar instances where the Aroon Indicator showed a similar pattern. In 139 of the 141 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a +18.42% 3-day Advance, the price is estimated to grow further. Considering data from situations where BWET advanced for three days, in 171 of 193 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.

Bearish Trend Analysis

The 10-day RSI Indicator for BWET moved out of overbought territory on September 22, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 34 similar instances where the indicator moved out of overbought territory. In 27 of the 34 cases, the stock moved lower in the following days. This puts the odds of a move lower at 79%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 40 of 47 cases where BWET's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 85%.

The Moving Average Convergence Divergence Histogram (MACD) for BWET turned negative on September 24, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 38 similar instances when the indicator turned negative. In 31 of the 38 cases the stock turned lower in the days that followed. This puts the odds of success at 82%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BWET declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.

BWET broke above its upper Bollinger Band on September 08, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Industry description

The investment seeks to provide investors with exposure to the daily change in the price of crude oil tanker freight futures before expenses and liabilities of the fund, by tracking the performance of a portfolio mainly consisting of the nearest calendar quarter of futures contracts on specified indexes that measure prices for shipping crude oil. Freight Futures reflect market expectations for the future cost of transporting crude oil. Each Reference index is published each United Kingdom business day by the London-based Baltic Exchange Ltd. and measures the charter rate for shipping crude oil in a specific size category of cargo ship and for a specific route.
View a ticker or compare two or three
BWET
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category CommoditiesBroadBasket

Category
Commodities Focused
Address
ETF Managers Group Commodity Trust I35 Beechwood Road,Suite BSummit
Phone
(908) 897-0510
Web
N/A
Interact to see
Advertisement
INSM shares are surging approximately +10% in premarket trading on Monday, March 23, 2026, from a prior close of $136.00, placing the premarket price near $149.60. The primary catalyst is the release of positive topline results from the Phase 3 ENCORE trial of ARIKAYCE® in patients with newly diagnosed or recurrent MAC (Mycobacterium avium complex) lung disease — a readout Insmed had flagged as expected in "March or April 2026".
CF shares are trading approximately -6% lower in Monday's premarket session, dropping from a Friday close of $124.90 to approximately $117.41. Primary catalyst: President Trump announced a five-day pause on strikes against Iranian energy infrastructure following "very good" diplomatic signals, triggering a sharp unwind of the geopolitical risk premium embedded in fertilizer stocks.
APGE shares surged approximately 16% in premarket trading on March 23, 2026, after the company announced positive 52-week data from Part A of its Phase 2 APEX clinical trial. The primary catalyst is a highly anticipated clinical readout showing that zumilokibart (APG777) delivered durable and deepening responses in patients with moderate-to-severe atopic dermatitis at both every 3-month and 6-month dosing intervals.
Shares of VALN are plummeting approximately 35% in Monday's session, from a Friday close of $10.66 to roughly $6.93, in heavy volume trading. The primary catalyst is the release of Phase 3 VALOR trial topline results for Valneva's Lyme disease vaccine candidate, co-developed with PFE (Pfizer) — results that showed strong clinical efficacy but failed to meet the pre-determined statistical criterion for the primary endpoint.
AXTI is surging approximately +11.00% in Monday's session, trading near $60.21, up from a prior closing price of $54.24. The move extends the stock's post-earnings rally that began last Thursday when shares jumped more than 19% following AXT's Q4 2025 results.
Tower Semiconductor (TSEM) shares are surging approximately +10% intraday on Monday, March 23, trading around $180, up from the previous close of $163.63 on March 20, 2026. The primary catalyst is the opening day of APEC 2026 in San Antonio, Texas, where Tower Semiconductor is presenting its newly unveiled Gen3 BCD power management platform designed to address escalating AI data center power demands.
CD is indicated down about 17% in premarket trading after the latest completed session, pointing to a sharp negative market reaction heading into the open. The stock’s weakness comes against a backdrop of lingering uncertainty following its privatization and delisting process from Nasdaq, which has left limited liquidity and a thinner news flow around the name.
SEDG is indicated down roughly 9% in premarket trading, following a strong advance in the prior regular session. The pullback comes after shares rallied on optimism around new product launches and an analyst upgrade, leaving the stock vulnerable to profit-taking and volatility.
NTGR shares surged approximately 11% in premarket trading on March 24, 2026, building on a roughly 20% overnight jump in the prior session. The primary catalyst is a landmark Federal Communications Commission (FCC) ruling that prohibits all imports of consumer routers manufactured overseas, citing national security concerns.
ANNA is surging approximately +20.00% in Tuesday's premarket session, rebounding sharply from Monday's -22.84% decline. The primary catalyst remains the ongoing U.S.-Iran military conflict, which disrupted Qatari LNG exports and drove European benchmark natural gas prices to multi-year highs.
Concentrix Corporation (CNXC) shares are falling approximately 11% in Tuesday's premarket session after the company released its fiscal Q1 2026 earnings report before market open. Adjusted diluted EPS came in at $2.61, missing the Wall Street consensus estimate of approximately $2.64.
Shares of Karyopharm Therapeutics (KPTI) are trading approximately 12% lower in Tuesday's premarket session, with the previous close at $7.63. The primary catalyst is the March 24 release of topline Phase 3 SENTRY trial data, in which the company met only one of two co-primary endpoints.
IBRX shares are down approximately 23% in Tuesday's session, trading near $7.24 after closing at $9.40 on Monday, March 23. The sharp decline follows an 11%+ surge in the prior session, with profit-taking and valuation pressure cited as primary triggers.
Shares of Circle Internet Group (CRCL) are down approximately 9% in Tuesday morning trading, extending a pullback from recent multi-month highs above $126. The primary catalyst appears to be a broad crypto-sector risk-off wave, with Bitcoin sliding below $69,000 and the Fear & Greed Index dropping to extreme fear territory.
ALM shares are indicated down about 11% in early Tuesday trading after closing the prior session at $16.93. The move comes after a powerful multi‑month rally that took the stock from below $3 to an intraday high of $22.55 earlier in March, leaving it vulnerable to profit-taking and volatility.​
LUNR shares are indicated down about 7% in Tuesday premarket trading after closing the last regular session at $20.31. The pullback follows a powerful rally driven by strong 2026 revenue guidance of $900 million–$1 billion and upbeat analyst commentary, including price target hikes and buy ratings.
MAZE shares are trading approximately 27% lower in premarket on March 25, 2026, after the company reported its highly anticipated Phase 2 HORIZON trial topline data for lead drug candidate MZE829. The catalyst is a dual announcement: Phase 2 clinical data for MZE829 in APOL1-mediated kidney disease (AMKD) alongside Q4 and full-year 2025 financial results.
ARM shares surged approximately +10% in premarket trading on March 25, 2026, hitting $148.6 from a prior close of approximately $135. The primary catalyst is Arm's historic strategic pivot: the company announced it will begin selling its own self-developed AGI CPU chips, breaking its decades-long "IP licensing only" business model.
Shares of Enliven Therapeutics (ELVN) are surging approximately +15% in premarket trading on March 25, 2026, driven by renewed investor enthusiasm around the company's advancing clinical program for ELVN-001 in chronic myeloid leukemia (CML). The stock's prior closing price on March 24, 2026 was $31.15, placing the premarket indicated price near $35.82.
AVXL shares are down approximately 29% in premarket trading on Wednesday, March 25, 2026, falling to roughly $2.97 from the prior close of $4.19. The primary catalyst is Anavex's formal withdrawal of its marketing authorization application (MAA) for blarcamesine from the European Union, announced in the early hours of March 25, 2026.